Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/27891
Title: | Treating Through Drug-Associated Exanthems in Drug Allergy Management: Current Evidence and Clinical Aspects. | Austin Authors: | Trubiano, Jason ;Soria, Angèle;Torres, Maria J;Trautmann, Axel | Affiliation: | Department of Medicine (Austin Health), University of Melbourne, Heidelberg, VIC, Australia Centre for Antibiotic Allergy and Research Sorbonne Universités, Paris, France; Service de Dermatologie et d'Allergologie, Hôpital Tenon, Paris HUEP, APHP, Paris, France; Centre d'Immunologie et des Maladies Infectieuses - Paris (Cimi-Paris), INSERM U1135, Paris, France.. Allergy Unit, IBIMA-Regional University Hospital of Malaga UMA, Malaga, Spain; Andalusian Center for Nanomedicine and Biotechnology - BIONAND, Malaga, Spain.. Department of Dermatology and Allergy, University Hospital Würzburg, Würzburg, Germany.. Infectious Diseases |
Issue Date: | Aug-2021 | Date: | 2021-04-17 | Publication information: | The Journal of Allergy and Clinical Immunology. In Practice 2021; 9(8): 2984-2993 | Abstract: | In the setting of an acute cutaneous adverse drug reaction there is increasing interest in selected phenotypes and hosts to continue drug therapy, especially in settings in which there are limited therapeutic options. This concept of "treating through," defined as the continued use of a drug in the setting of, in particular maculopapular exanthema, potentially avoids unnecessary drug discontinuation. A review of the recent literature, historical viewpoints, and expert opinion are provided within to form recommendations and algorithms for a "treating-through" approach. | URI: | https://ahro.austin.org.au/austinjspui/handle/1/27891 | DOI: | 10.1016/j.jaip.2021.04.008 | Journal: | The Journal of Allergy and Clinical Immunology. In Practice | PubMed URL: | 33878455 | Type: | Journal Article | Subjects: | Drug Allergy Management |
Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.